Possible association of heart failure status with synthetic balance between aldosterone and dehydroepiandrosterone in human heart

Circulation

Volumn 110, Issue 13, 2004, Pages 1787-1793

  Nakamura, Shota ^a   Yoshimura, Michihiro ^a   Nakayama, Masafumi ^a   Ito, Teruhiko ^b   Mizuno, Yuji ^b   Harada, Eisaku ^b   Sakamoto, Tomohiro ^a   Saito, Yoshihiko ^c   Nakao, Kazuwa ^d   Yasue, Hirofumi ^b   Ogawa, Hisao ^a  

^a KUMAMOTO UNIVERSITY   (Japan)

^b Kumamoto Aging Research Institute   (Japan)

^c NARA MEDICAL UNIVERSITY   (Japan)

^d KYOTO UNIVERSITY GRADUATE SCHOOL OF MEDICINE   (Japan)

Author keywords

Cardiomyopathy; Heart failure; Hormones; Hypertrophy; Natriuretic peptides

Indexed keywords

ALDOSTERONE; BRAIN NATRIURETIC PEPTIDE; CYTOCHROME P450 17; ENDOTHELIN 1; HYDROCORTISONE; MESSENGER RNA; PRASTERONE; RNA;

ADRENAL GLAND; ADULT; AGED; ALDOSTERONE BLOOD LEVEL; ANIMAL CELL; ARTICLE; CLINICAL ARTICLE; CONGESTIVE CARDIOMYOPATHY; CONTROLLED STUDY; FEMALE; GENE EXPRESSION; HEART FAILURE; HEART INFARCTION; HEART LEFT VENTRICLE; HEART MUSCLE CELL; HEART PROTECTION; HUMAN; HUMAN CELL; HUMAN TISSUE; HYPERTENSION; HYPERTROPHIC CARDIOMYOPATHY; MALE; NEWBORN; NONHUMAN; PRIORITY JOURNAL; RAT; REVERSE TRANSCRIPTION POLYMERASE CHAIN REACTION; SOUTHERN BLOTTING;

ADULT; AGED; ALDOSTERONE; ANIMALS; BLOTTING, SOUTHERN; CELL SIZE; CELLS, CULTURED; DEHYDROEPIANDROSTERONE; ENDOTHELIN-1; FEMALE; HEART CATHETERIZATION; HEART FAILURE, CONGESTIVE; HEART VENTRICLES; HUMANS; HYPERTROPHY; MALE; MIDDLE AGED; MYOCYTES, CARDIAC; NATRIURETIC PEPTIDE, BRAIN; NEOPLASMS; RATS; REVERSE TRANSCRIPTASE POLYMERASE CHAIN REACTION; RNA, MESSENGER; STEROID 11-BETA-HYDROXYLASE; STEROID 17-ALPHA-HYDROXYLASE;

EID: 20844440035     PISSN: 00097322     EISSN: None     Source Type: Journal    
DOI: 10.1161/01.CIR.0000143072.36782.51     Document Type: Article

References (38)

1. Hatakeyama H, Miyamori I, Fujita T, et al. Vascular aldosterone: biosynthesis and a link to angiotensin II-induced hypertrophy of vascular smooth muscle cells. J Biol Chem. 1994;269:24316-24320.
2. Gomez-Sanchez CE, Zhou MY, Cozza EN, et al. Aldosterone biosynthesis in the rat brain. Endocrinology. 1997;138:3369-3373.
3. Silvestre JS, Robert V, Heymes C, et al. Myocardial production of aldosterone and corticosterone in the rat: physiological regulation. J Biol Chem. 1998;273:4883-4891.
4. Takeda Y, Yoneda T, Demura M, et al. Cardiac aldosterone production in genetically hypertensive rats. Hypertension. 2000;36:495-500.
5. Mizuno Y, Yoshimura M, Yasue H, et al. Aldosterone production is activated in the failing ventricles in humans. Circulation. 2001;103: 72-77.
6. White PC. Disorders of aldosterone biosynthesis and action. N Engl J Med. 1994;331:250-258.
7. Kayes-Wandover KM, White PC. Steroidogenic enzyme gene expression in the human heart. J Clin Endocrinol Metab. 2000;85:2519-2525.
8. Young MJ, Clyne CD, Cole TJ, et al. Cardiac steroidogenesis in the normal and failing heart. J Clin Endocrinol Metab. 2001;86:5121-5126.
9. Yoshimura M, Nakamura S, Ito T, et al. Expression of aldosterone synthase gene in the failing human heart: quantitative analysis using modified real-time PCR. J Clin Endocrinol Metab. 2002;87:3936-3940.
10. Slominski A, Ermak G, Mihm M. ACTH receptor, CYP11A1, CYP17 and CYP21A2 genes are expressed in skin. J Clin Endocrinol Metab. 1996;81:2746-2749.
11. Le Goascogne C, Sananes N, Eychenne B, et al. Androgen biosynthesis in the stomach: expression of cytochrome P450 17α-hydroxylase/17,20-lyase messenger ribonucleic acid and protein, and metabolism of pregnenolone and progesterone by parietal cells of the rat gastric mucosa. Endocrinology. 1995;136:1744-1752.
12. Dalla Valle L, Couet J, Labrie Y, et al. Occurrence of cytochrome P450c17 mRNA and dehydroepiandrosterone biosynthesis in the rat gastrointestinal tract. Mol Cell Endocrinol. 1995;111:83-92.
13. Vianello S, Waterman MR, Dalla Valle L, et al. Developmentally regulated expression and activity of 17α-hydroxylase/C-17,20-lyase cytochrome P450 in rat liver. Endocrinology. 1997;138:3166-3174.
14. Compagnone NA, Bulfone A, Rubenstein JL, et al. Steroidogenic enzyme P450c17 is expressed in the embryonic central nervous system. Endocrinology. 1995;136:5212-5223.
15. Baulieu EE, Robel P. Dehydroepiandrosterone (DHEA) and dehydroepiandrosterone sulfate (DHEAS) as neuroactive neurosteroids. Proc Natl Acad Sci U S A. 1998;95:4089-4091.
16. Zwain IH, Yen SS. Dehydroepiandrosterone: biosynthesis and metabolism in the brain. Endocrinology. 1999;140:880-887.
17. Miller WL, Auchus RJ, Geller DH. The regulation of 17,20-lyase activity. Steroids. 1997;62:133-142.
18. Parker LN, Odell WD. Control of adrenal androgen secretion. Endocr Rev. 1980;1:392-410.
19. Orentreich N, Brind JL, Rizer RL, et al. Age changes and sex differences in serum dehydroepiandrosterone sulfate concentrations throughout adulthood. J Clin Endocrinol Metab. 1984;59:551-555.
20. Barrett-Connor E, Khaw KT, Yen SS. A prospective study of dehydroepiandrosterone sulfate, mortality, and cardiovascular disease. N Engl J Med. 1986;315:1519-1524.
21. Mitchell LE, Sprecher DL, Borecki IB, et al. Evidence for an association between dehydroepiandrosterone sulfate and nonfatal, premature myocardial infarction in males. Circulation. 1994;89:89-93.
22. Moriyama Y, Yasue H, Yoshimura M, et al. The plasma levels of dehydroepiandrosterone sulfate are decreased in patients with chronic heart failure in proportion to the severity. J Clin Endocrinol Metab. 2000;85:1834-1840.
23. Harada M, Itoh H, Nakagawa O, et al. Significance of ventricular myocytes and nonmyocytes interaction during cardiocyte hypertrophy: evidence for endothelin-1 as a paracrine hypertrophic factor from cardiac nonmyocytes. Circulation. 1997;96:3737-3744.
24. Gray H. Anatomy of the Human Body. New York: Bartleby; 2000.
25. Labrie F. Intracrinology. Mol Cell Endocrinol. 1991;78:C113-C118.
26. Lin D, Black SM, Nagahama Y, et al. Steroid 17α-hydroxylase and 17,20-lyase activities of P450c17: contributions of serine106 and P450 reductase. Endocrinology. 1993;132:2498-2506.
27. Nawata H, Yanase T, Goto K, et al. Mechanism of action of anti-aging DHEA-S and the replacement of DHEA-S. Mech Ageing Dev. 2002;123: 1101-1106.
28. Hokimoto S, Yasue H, Fujimoto K, et al. Expression of angiotensin-converting enzyme in remaining viable myocytes of human ventricles after myocardial infarction. Circulation. 1996;94:1513-1518.
29. Rajagopalan S, Duquaine D, King S, et al. Mineralocorticoid receptor antagonism in experimental atherosclerosis. Circulation. 2002;105: 2212-2216.
30. Gordon GB, Bush DE, Weisman HF. Reduction of atherosclerosis by administration of dehydroepiandrosterone: a study in the hypercholesterolemic New Zealand white rabbit with aortic intimal injury. J Clin Invest. 1988;82:712-720.
31. Williams MR, Ling S, Dawood T, et al. Dehydroepiandrosterone inhibits human vascular smooth muscle cell proliferation independent of ARs and ERs. J Clin Endocrinol Metab. 2002;87:176-181.
32. Liu D, Dillon JS. Dehydroepiandrosterone activates endothelial cell nitric-oxide synthase by a specific plasma membrane receptor coupled to Gαi2,3. J Biol Chem. 2002;277:21379-21388.
33. Labrie F, Luu-The V, Labrie C, et al. Endocrine and intracrine sources of androgens in women: inhibition of breast cancer and other roles of androgens and their precursor dehydroepiandrosterone. Endocr Rev. 2003;24:152-182.
34. Grohe C, Kahlert S, Lobbert K, et al. Expression of oestrogen receptor alpha and beta in rat heart: role of local oestrogen synthesis. J Endocrinol. 1998;156:R1-R7.
35. Van Cauter E, Leproult R, Kupfer DJ. Effects of gender and age on the levels and circadian rhythmicity of plasma cortisol. J Clin Endocrinol Metab. 1996;81:2468-2473.
36. Walker BR, Phillips DI, Noon JP, et al. Increased glucocorticoid activity in men with cardiovascular risk factors. Hypertension. 1998;31:891-895.
37. Heid CA, Stevens J, Livak KJ, et al. Real-time quantitative PCR. Genome Res. 1996;6:986-994.
38. Sun Y, Zhang J, Lu L, et al. Aldosterone-induced inflammation in the rat heart: role of oxidative stress. Am J Pathol. 2002;161:1773-1781.